a 2025

Systematic Assessment of the Applicability of Comprehensive Genomic Testing Towards Better Cancer Clinical Diagnostics in the Czech Republic

PLEVOVÁ, Karla; Sabina PEŇÁZOVÁ; Patricie SKALÁKOVÁ; Jakub Paweł PORC; Hana SVOZILOVÁ et al.

Basic information

Original name

Systematic Assessment of the Applicability of Comprehensive Genomic Testing Towards Better Cancer Clinical Diagnostics in the Czech Republic

Authors

PLEVOVÁ, Karla; Sabina PEŇÁZOVÁ; Patricie SKALÁKOVÁ; Jakub Paweł PORC; Hana SVOZILOVÁ; Karolína ČERNOVSKÁ; Kamila STRÁNSKÁ; Eva ONDROUŠKOVÁ; Marie JAROŠOVÁ; Michael DOUBEK; Jana KOTAŠKOVÁ; Magdalena UVIROVA; Zuzana ZEMANOVA and Šárka POSPÍŠILOVÁ

Edition

Clinical Cancer Genomics Conference, Amsterodam, 2025

Other information

Language

English

Type of outcome

Konferenční abstrakta

Country of publisher

Netherlands

Confidentiality degree

is not subject to a state or trade secret

References:

Marked to be transferred to RIV

No

Organization

Středoevropský technologický institut – Repository – Repository

Keywords in English

comprehensive genomic testing; whole-genome sequencing (WGS); chronic lymphocytic leukemia; clinical cancer diagnostics

Links

EH23_020/0008555, research and development project.
Changed: 11/2/2026 00:50, RNDr. Daniel Jakubík

Abstract

In the original language

gt;20% mitoses) but repeatedly failed to detect specific rearrangements, such as dicentric chromosomes and derived chromosomes involving more than two chromosomes. For this purpose, the analysis against the T2T reference would be beneficial. Overall, we uncovered significantly greater SV complexity in all ten cases by combining short-read WGS, ONT, and OGM than identified by low-throughput methods. These pilot data will serve to adjust the analytical approaches for further larger patient cohorts.

Files attached